Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China flag China · Delayed Price · Currency is CNY
90.38
-2.08 (-2.25%)
Aug 24, 2026, 3:00 PM CST

SHA:688016 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
588.53563.33502.1492.43356.88315.86
Depreciation & Amortization
75.4375.4350.0135.2733.1723.71
Other Amortization
14.2814.2810.6610.9510.832.86
Loss (Gain) From Sale of Assets
--0.660.10.230.06
Asset Writedown & Restructuring Costs
0.090.09-6.352.232.62
Loss (Gain) From Sale of Investments
-16.34-16.34-87.41-9.15-4.1-15.01
Provision & Write-off of Bad Debts
8.318.313.251.342.631.28
Other Operating Activities
-47.067.49-4.78-0.79-2.4-6.77
Change in Accounts Receivable
90.9390.93-157.78-31.75-48.38-41.56
Change in Inventory
-14.37-14.37-21.04-61.27-51.29-27.48
Change in Accounts Payable
-159.01-159.0165.12105.9215.2540.17
Change in Other Net Operating Assets
14.2914.2918.2218.0515.4510.88
Operating Cash Flow
543.72573.06373.6558.31333.76300.25
Operating Cash Flow Growth
169.59%53.39%-33.08%67.28%11.16%38.09%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-231.78-303.03-212.65-190.26-293.98-89.58
Sale of Property, Plant & Equipment
0.02-0.04---
Cash Acquisitions
---453.05--133.33-
Investment in Securities
70-100-97.5-10.11--
Other Investing Activities
16.715.9830.0223.28-12.515.01
Investing Cash Flow
-145.07-387.06-733.14-177.09-439.8-74.57

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-12614---
Long-Term Debt Issued
----2.09-
Total Debt Issued
-12614-2.09-
Short-Term Debt Repaid
--140--2.12--
Long-Term Debt Repaid
--13.98-13.51-12.42-10.9-8.48
Total Debt Repaid
-153.98-153.98-13.51-14.54-10.9-8.48
Net Debt Issued (Repaid)
-153.98-27.980.49-14.54-8.81-8.48
Issuance of Common Stock
---1,781--
Repurchase of Common Stock
-120.11-120.11-120---
Common Dividends Paid
-201.15-201.83-450.46-165.55-151.15-64.78
Other Financing Activities
71.83-35--33.41
Financing Cash Flow
-403.4-349.92-534.981,601-159.96-39.85

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
4.08-2.870.24---
Net Cash Flow
-0.67-166.78-894.271,983-266185.84

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
311.93270.03160.95368.0539.78210.67
Free Cash Flow Growth
-67.77%-56.27%825.13%-81.12%10.17%
Free Cash Flow Margin
22.46%19.99%13.34%31.00%4.44%30.77%
Free Cash Flow Per Share
2.592.231.303.420.371.97
Levered Free Cash Flow
239.51122.1229.74248.59-79.41107.26
Unlevered Free Cash Flow
240.35123.4730.77249.73-78.1108.36

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
199.36178.45284.06174.23140.79-
Change in Working Capital
-79.51-79.51-100.8821.8-65.7-24.35